ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 181 - 190 of 271
Presenter(s): Brenda C Seal, PhD, CCC-SLP; Lissa Power-deFur, PhD, CCC-SLP, BCS-CL
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: An expert witness is responsible for providing specialized knowledge to assist in understanding the evidence or determining a fact at issue in a criminal, civil, or special education due process proceeding. This session will provide an overview of the roles, responsibilities, and qualifications of an SLP who may be asked to serve in an expert witness role.
Presenter(s): Devin L. McCaslin, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session will examine the diagnosis and treatment of persistent postural-perceptual dizziness (PPPD). The session will explore the recently defined criteria for the presentation and symptoms of the disorder as well as describe current and emerging research that is helping clinicians and researchers better understand it. The speaker will also discuss how chronic co-morbid disorders such as migraine and Meniere’s disease should be factored into the treatment of this disorder.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Credit(s): PDHs: 3.5, ASHA CEUs*: 0.35
Summary: These SIG 17 Perspectives articles focus on the impact of the COVID-19 global pandemic on service provision and student training in four global contexts: Cyprus, South Africa, the United Kingdom, and the United States. Topics include the rise of telesupervision, telepractice in speech-language pathology (SLP), and distance learning in Cyprus during COVID-19; the effectiveness of SLP and related service treatment of patients with COVID-19 in an inpatient rehabilitation setting in the United States; the impact and transformation of an SLP university program in South Africa due to COVD-19; and the perspectives of parents/caregivers on SLP service provision during the pandemic for children born with cleft palates in the United Kingdom.
Presenter(s): Andrea Martinez-Fisher, MS, CCC-SLP; Taite Winter, MS, CCC-SLP; Phyllis M Palmer, PhD, CCC-SLP; Shauna Murray, MS, CCC-SLP; Aaron Henry Padilla, MS, CCC-SLP, BCS-S
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a project that investigated the effect of lower temporal resolutions on assessment of videofluoroscopic evaluation of swallowing (VFES) in adult and infant populations.
Presenter(s): Dusty Jessen, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The provision of comprehensive auditory rehabilitation services is critical to successful patient outcomes, yet many audiologists focus primarily or exclusively on amplification due to time, reimbursement, and compliance challenges. This session will clearly define the components of auditory rehabilitation and provide specific strategies and tools to help overcome challenges.
Presenter(s): Vickie L. Tuten, AuD, CCC-A, CPS/A; Kathy E. Gates, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Noise is prevalent in everyday life, and the general population lacks awareness of the risks of hazardous noise exposure and strategies to reduce noise-induced hearing loss. By integrating hearing loss prevention education into patient encounters and taking advantage of outreach/education opportunities, audiologists can help reduce the prevalence of noise-induced hearing loss. This course discusses the why, where, and how of integrating prevention education into your practice.
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This Perspectives activity highlights two articles with objective measures for both evaluation and treatment of velopharyngeal dysfunction. The first article discusses the palatal closure efficiency (PaCE) index. This is an aerodynamic tool used to estimate the velopharyngeal opening during certain speech contexts. This is done by measuring a percentage of change between nasal and oral cognates of an individual. The second article describes the nasometer in depth, highlighting its use as an evaluation and treatment tool for decreasing hypernasality. It goes into further detail on the differences between hypernasality and measured nasalance, highlighting both strengths and limitations of the nasalance score.
<< 15 16 17 18 19 20 21 22 23 24 >>